Aetion has named Carolyn Magill CEO of the New York-based company. Magill most recently served as CEO of Darien, CT-based Remedy Partners. Aetion, a health IT startup, has developed software that analyzes clinical and financial activity to find evidence supporting the efficacy and value of treatments. In March, Aetion raised $11 million in a Series A round of financing.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
